Welcome to the digital portfolio of Michael W. Hoskins, an award-winning journalist and editorial leader with more than two decades of experience managing medical, healthcare, and patient advocacy content. This archive highlights more than a decade of journalism and media brand-shaping coverage across Healthline Media and DiabetesMine.
Featured Healthcare Journalism & Editorial Work
Explore an online archive of my health journalism and editorial work published across Healthline Media between 2022 and 2026.
Highlights from my Healthline tenure:
- Managed my own reporting and editing of 12-36 monthly health articles, integrating AI generative tools into the workflow while maintaining a distinct editorial voice and strict brand standards.
- Improved click-through-rates by over 15% and consistently exceeded quarterly annual traffic KPIs by double digits.
- Created new sponsored newsletters and repurposed outdated content marketing articles, leading to 25% higher known user acquisitions and increasing revenue by 33% in key health topic areas.
- Managed cross-functional teams of writers, medical reviewers, and designers to achieve editorial goals and consistently improve audience engagement by over 20%.
- Spearheaded the revitalization of Healthline’s diabetes content portfolio, implementing SEO and editorial strategies to redirect, refresh, and repurpose de-indexed content.
- Led a new multi-team initiative to link and strengthen Healthline’s breaking news, clinical content, and weekly newsletters to drive traffic, improve audience engagement, and increase media revenue.
- Collaborated within a 9-month tiger team to develop and launch OptumNow, a first-of-its-kind consumer health platform to modernize healthcare navigation.
Explore a collection of my editorial work at DiabetesMine, from 2012 to 2022.
Investigative Enterprise Journalism
- Four-part series on FDA Diabetes Device Recalls
News Coverage
- Newsflash: Diabetes Hands Foundation Merges with Beyond Type 1
- Tidepool Loop: The App for Automating Insulin Delivery
- Thousands Tune In for American Diabetes Association Virtual Scientific Sessions
- FDA OKs First Needle-Free Nasal Glucagon (Baqsimi) for Severe Hypoglycemia
- Newsflash: Animas Exiting Insulin Pump Market
- Newsflash: Roche Stops Selling Accu-Chek Insulin Pumps in US
Business Reviews and Profiles
High-Profile Interviews
Tributes
Let's collaborate. Connect with me to discuss editorial leadership, content strategy, or consulting opportunities.
View Full Profile & Connect on LinkedIn